ing. A.H. Meter

Faculty of Medical Sciences

Telephone:

E-mail:

a.h.meter-arkema umcg.nl

Research Portal

Publications

Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways

Faria, B., da Costa, M. G., Meter-Arkema, A. H., Berger, S. P., Lima, C., Pêgo, C., van den Born, J., Franssen, C. F., Daha, M. R., Pestana, M., Seelen, M. A. & Poppelaars, F., Jan-2024, In: Peritoneal dialysis international. 44, 1, p. 37–47 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys

PROPER study consortium, Jager, N. M., Venema, L. H., Arykbaeva, A. S., Meter-Arkema, A. H., Ottens, P. J., van Kooten, C., Mollnes, T. E., Alwayn, I. P. J., Leuvenink, H. G. D. & Pischke, S. E., 13-Jul-2022, In: Frontiers in Immunology. 13, 12 p., 831371.

Research output: Contribution to journal › Article › Academic › peer-review

Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney

COMBAT Consortium, Tiller, G., Lammerts, R. G. M., Karijosemito, J. J., Alkaff, F. F., Diepstra, A., Pol, R. A., Meter-Arkema, A. H., Seelen, M. A., van den Heuvel, M. C., Hepkema, B. G., Daha, M. R., van den Born, J. & Berger, S. P., 13-Apr-2022, In: Frontiers in Immunology. 13, 17 p., 845301.

Research output: Contribution to journal › Article › Academic › peer-review

TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODYMEDIATED REJECTION

Tiller, G., Lammerts, R., Karijosemito, J. J., Diepstra, A., Meter, A. H., Seelen, M., van den Heuvel, M., Hepkema, B., van den Born, J. & Berger, S., Aug-2021, In: Transplant International. 34, p. 10-10 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Validation of C3, IC3b, C3d, C4d, properdin C5 and C5b-9 assays to monitor complement activation in kidney transplant patients

Lammerts, R., Jager, T., Meter, A. H., Seelen, M., van den Born, J., Berger, S. & Daha, M., Aug-2021, In: Transplant International. 34, p. 251-251 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides

COMBAT Consortium, Talsma, D. T., Poppelaars, F., Dam, W., Meter-Arkema, A. H., Vivès, R. R., Gál, P., Boons, G.-J., Chopra, P., Naggi, A., Seelen, M. A., Berger, S. P., Daha, M. R., Stegeman, C. A. & van den Born, J., 28-Apr-2020, In: Frontiers in Immunology. 11, 17 p., 732.

Research output: Contribution to journal › Article › Academic › peer-review

All (19) publications

View full research profile

ing. A.H. Meter

Publications

Systemic and local complement activation in peritoneal dialysis patients via conceivably distinct pathways

Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys

Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney

TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODYMEDIATED REJECTION

Validation of C3, IC3b, C3d, C4d, properdin C5 and C5b-9 assays to monitor complement activation in kidney transplant patients

MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides

Erratum to: Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients

Low mannose-binding lectin levels predict cardiovascular disease in hemodialysis patients

Low mannose-binding lectinlevels predict cardiovascular disease in hemodialysis patients

Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients